Table 1.
T-cell densities (cells/mm2) by p53 status in combined matched-race TMA sets
CD3+ density |
CD8+ density |
FOXP3+ density |
|||||||
---|---|---|---|---|---|---|---|---|---|
n (387) | Median | P a | n (388) | Median | P a | n (206) | Median | P a | |
Overall | |||||||||
p53 negative b | 367 | 230.8 | .004 * | 368 | 66.3 | .1 | |||
p53 positive c | 20 | 341.3 | 20 | 90.7 | |||||
European American | |||||||||
p53 negative b | 192 | 220.6 | .03 * | 192 | 76.9 | .4 | |||
p53 positive c | 14 | 301.5 | 14 | 88.4 | |||||
African American | |||||||||
p53 negative b | 175 | 241.5 | .02 * | 176 | 57.0 | .05 * | 179 | 15.9 | .04 * |
p53 positive c | 6 | 486.3 | 6 | 104.8 | 6 | 34.0 |
NOTE. FOXP3 immunostaining was unevaluable on a subset of the European American tumors from the matched-race TMA set because of a faulty batch of slides, which were incompatible with Ventana immunostainer. Thus, these data are not included. CD3 and CD8 immunostaining was unevaluable in 4 and 3 African American cases from the race TMA set because of poor staining, respectively.
Kruskal-Wallis test.
Absence of p53 nuclear accumulation.
Presence of p53 nuclear accumulation.
P < .05.